Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-4 Registration of securities (foreign)
- 3.2 Exhibit 3.2
- 4.5 Exhibit 4.5
- 4.6 Exhibit 4.6
- 5.1 Exhibit 5.1
- 5.2 Exhibit 5.2
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.9 Exhibit 10.9
- 10.10 Exhibit 10.10
- 10.11 Exhibit 10.11
- 10.12 Exhibit 10.12
- 10.13 Exhibit 10.13
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
- 23.3 Exhibit 23.3
- 23.7 Exhibit 23.7
- 99.2 Exhibit 99.2
- 99.3 Exhibit 99.3
- 99.4 Exhibit 99.4
- 99.5 Exhibit 99.5
- EX-FILING FEES Ex-filing Fees
Associated filings
- 21 Feb 23 424B3 Prospectus supplement
- 8 Feb 23 424B3 Prospectus supplement
- 8 Feb 23 EFFECT Notice of effectiveness
- 3 Feb 23 F-4/A Registration of securities (foreign) (amended)
- 25 Jan 23 F-4/A Registration of securities (foreign) (amended)
- 13 Jan 23 F-4/A Registration of securities (foreign) (amended)
-
28 Dec 22 F-4 Registration of securities (foreign)
LSB similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form F-4 of YishengBio Co., Ltd. of our report dated September 28, 2022, relating to the consolidated financial statements of YishengBio Co., Ltd. and Subsidiaries for the years ended March 31, 2022 and 2021, which appear in this Registration Statement.
We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Wei, Wei & Co., LLP
Flushing, New York December 28, 2022 |
1